Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1997 Sep;77(2):F81–F84. doi: 10.1136/fn.77.2.f81

Inhaled nitric oxide in neonates

N FINER
PMCID: PMC1720701  PMID: 9377150

Full Text

The Full Text of this article is available as a PDF (93.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abman S. H., Chatfield B. A., Hall S. L., McMurtry I. F. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol. 1990 Dec;259(6 Pt 2):H1921–H1927. doi: 10.1152/ajpheart.1990.259.6.H1921. [DOI] [PubMed] [Google Scholar]
  2. Abman S. H., Kinsella J. P., Schaffer M. S., Wilkening R. B. Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics. 1993 Oct;92(4):606–609. [PubMed] [Google Scholar]
  3. Atz A. M., Adatia I., Wessel D. L. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg. 1996 Dec;62(6):1759–1764. doi: 10.1016/s0003-4975(96)00542-5. [DOI] [PubMed] [Google Scholar]
  4. Austin A. T. The chemistry of the higher oxides of nitrogen as related to the manufacture, storage and administration of nitrous oxide. Br J Anaesth. 1967 May;39(5):345–350. doi: 10.1093/bja/39.5.345. [DOI] [PubMed] [Google Scholar]
  5. Barbotin-Larrieu F., Mazmanian M., Baudet B., Détruit H., Chapelier A., Libert J. M., Dartevelle P., Hervé P. Prevention of ischemia-reperfusion lung injury by inhaled nitric oxide in neonatal piglets. J Appl Physiol (1985) 1996 Mar;80(3):782–788. doi: 10.1152/jappl.1996.80.3.782. [DOI] [PubMed] [Google Scholar]
  6. Barefield E. S., Karle V. A., Phillips J. B., 3rd, Carlo W. A. Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr. 1996 Aug;129(2):279–286. doi: 10.1016/s0022-3476(96)70255-x. [DOI] [PubMed] [Google Scholar]
  7. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1620–1624. doi: 10.1073/pnas.87.4.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Benzing A., Bräutigam P., Geiger K., Loop T., Beyer U., Moser E. Inhaled nitric oxide reduces pulmonary transvascular albumin flux in patients with acute lung injury. Anesthesiology. 1995 Dec;83(6):1153–1161. doi: 10.1097/00000542-199512000-00004. [DOI] [PubMed] [Google Scholar]
  9. Bouchet M., Renaudin M. H., Raveau C., Mercier J. C., Dehan M., Zupan V. Safety requirement for use of inhaled nitric oxide in neonates. Lancet. 1993 Apr 10;341(8850):968–969. doi: 10.1016/0140-6736(93)91267-p. [DOI] [PubMed] [Google Scholar]
  10. Cooke J. P., Tsao P. S. Cytoprotective effects of nitric oxide. Circulation. 1993 Nov;88(5 Pt 1):2451–2454. doi: 10.1161/01.cir.88.5.2451. [DOI] [PubMed] [Google Scholar]
  11. Curtis J., O'Neill J. T., Pettett G. Endotracheal administration of tolazoline in hypoxia-induced pulmonary hypertension. Pediatrics. 1993 Sep;92(3):403–408. [PubMed] [Google Scholar]
  12. Day R. W., Lynch J. M., White K. S., Ward R. M. Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics. 1996 Oct;98(4 Pt 1):698–705. [PubMed] [Google Scholar]
  13. Finer N. N., Etches P. C., Kamstra B., Tierney A. J., Peliowski A., Ryan C. A. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr. 1994 Feb;124(2):302–308. doi: 10.1016/s0022-3476(94)70324-8. [DOI] [PubMed] [Google Scholar]
  14. Frostell C. G., Lönnqvist P. A., Sonesson S. E., Gustafsson L. E., Löhr G., Noack G. Near fatal pulmonary hypertension after surgical repair of congenital diaphragmatic hernia. Successful use of inhaled nitric oxide. Anaesthesia. 1993 Aug;48(8):679–683. doi: 10.1111/j.1365-2044.1993.tb07179.x. [DOI] [PubMed] [Google Scholar]
  15. Gerlach H., Rossaint R., Pappert D., Falke K. J. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest. 1993 Aug;23(8):499–502. doi: 10.1111/j.1365-2362.1993.tb00797.x. [DOI] [PubMed] [Google Scholar]
  16. Gerlach H., Rossaint R., Pappert D., Knorr M., Falke K. J. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet. 1994 Feb 26;343(8896):518–519. doi: 10.1016/s0140-6736(94)91465-6. [DOI] [PubMed] [Google Scholar]
  17. Gessler P., Nebe T., Birle A., Mueller W., Kachel W. A new side effect of inhaled nitric oxide in neonates and infants with pulmonary hypertension: functional impairment of the neutrophil respiratory burst. Intensive Care Med. 1996 Mar;22(3):252–258. doi: 10.1007/BF01712246. [DOI] [PubMed] [Google Scholar]
  18. Goldman A. P., Tasker R. C., Haworth S. G., Sigston P. E., Macrae D. J. Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics. 1996 Oct;98(4 Pt 1):706–713. [PubMed] [Google Scholar]
  19. Greenbaum R., Bay J., Hargreaves M. D., Kain M. L., Kelman G. R., Nunn J. F., Prys-Roberts C., Siebold K. Effects of higher oxides of nitrogen on the anaesthetized dog. Br J Anaesth. 1967 May;39(5):393–404. doi: 10.1093/bja/39.5.393. [DOI] [PubMed] [Google Scholar]
  20. Gruetter C. A., Gruetter D. Y., Lyon J. E., Kadowitz P. J., Ignarro L. J. Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther. 1981 Oct;219(1):181–186. [PubMed] [Google Scholar]
  21. Henneberg S. W., Jepsen S., Andersen P. K., Pedersen S. A. Inhalation of nitric oxide as a treatment of pulmonary hypertension in congenital diaphragmatic hernia. J Pediatr Surg. 1995 Jun;30(6):853–855. doi: 10.1016/0022-3468(95)90763-7. [DOI] [PubMed] [Google Scholar]
  22. Högman M., Frostell C., Arnberg H., Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet. 1993 Jun 26;341(8861):1664–1665. doi: 10.1016/0140-6736(93)90802-n. [DOI] [PubMed] [Google Scholar]
  23. Högman M., Frostell C., Arnberg H., Sandhagen B., Hedenstierna G. Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand. 1994 May;151(1):125–129. doi: 10.1111/j.1748-1716.1994.tb09728.x. [DOI] [PubMed] [Google Scholar]
  24. Ignarro L. J., Adams J. B., Horwitz P. M., Wood K. S. Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms. J Biol Chem. 1986 Apr 15;261(11):4997–5002. [PubMed] [Google Scholar]
  25. Karamanoukian H. L., Glick P. L., Zayek M., Steinhorn R. H., Zwass M. S., Fineman J. R., Morin F. C., 3rd Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios. Pediatrics. 1994 Nov;94(5):715–718. [PubMed] [Google Scholar]
  26. Kinsella J. P., McQueston J. A., Rosenberg A. A., Abman S. H. Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation. Am J Physiol. 1992 Sep;263(3 Pt 2):H875–H880. doi: 10.1152/ajpheart.1992.263.3.H875. [DOI] [PubMed] [Google Scholar]
  27. Kinsella J. P., Neish S. R., Ivy D. D., Shaffer E., Abman S. H. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr. 1993 Jul;123(1):103–108. doi: 10.1016/s0022-3476(05)81551-3. [DOI] [PubMed] [Google Scholar]
  28. Kinsella J. P., Neish S. R., Shaffer E., Abman S. H. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992 Oct 3;340(8823):819–820. doi: 10.1016/0140-6736(92)92687-b. [DOI] [PubMed] [Google Scholar]
  29. Kinsella J. P., Schmidt J. M., Griebel J., Abman S. H. Inhaled nitric oxide treatment for stabilization and emergency medical transport of critically ill newborns and infants. Pediatrics. 1995 May;95(5):773–776. [PubMed] [Google Scholar]
  30. Kinsella J. P., Torielli F., Ziegler J. W., Ivy D. D., Abman S. H. Dipyridamole augmentation of response to nitric oxide. Lancet. 1995 Sep 2;346(8975):647–648. doi: 10.1016/s0140-6736(95)91487-0. [DOI] [PubMed] [Google Scholar]
  31. Lavoie A., Hall J. B., Olson D. M., Wylam M. E. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1985–1987. doi: 10.1164/ajrccm.153.6.8665066. [DOI] [PubMed] [Google Scholar]
  32. Lowson S. M., Rich G. F., McArdle P. A., Jaidev J., Morris G. N. The response to varying concentrations of inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesth Analg. 1996 Mar;82(3):574–581. doi: 10.1097/00000539-199603000-00026. [DOI] [PubMed] [Google Scholar]
  33. Miller O. I., Celermajer D. S., Deanfield J. E., Macrae D. J. Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg. 1994 Sep;108(3):487–494. [PubMed] [Google Scholar]
  34. Miller O. I., Tang S. F., Keech A., Celermajer D. S. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet. 1995 Jul 1;346(8966):51–52. doi: 10.1016/s0140-6736(95)92681-x. [DOI] [PubMed] [Google Scholar]
  35. Moglia B. B., Phelps D. S. Changes in surfactant protein A mRNA levels in a rat model of insulin-treated diabetic pregnancy. Pediatr Res. 1996 Feb;39(2):241–247. doi: 10.1203/00006450-199602000-00009. [DOI] [PubMed] [Google Scholar]
  36. Morita K., Ihnken K., Buckberg G. D., Sherman M. P., Ignarro L. J. Pulmonary vasoconstriction due to impaired nitric oxide production after cardiopulmonary bypass. Ann Thorac Surg. 1996 Jun;61(6):1775–1780. doi: 10.1016/0003-4975(96)00146-4. [DOI] [PubMed] [Google Scholar]
  37. Oriot D., Boussemart T., Berthier M., Bonneau D., Coisne D. Paradoxical effect of inhaled nitric oxide in a newborn with pulmonary hypertension. Lancet. 1993 Aug 7;342(8867):364–365. doi: 10.1016/0140-6736(93)91504-f. [DOI] [PubMed] [Google Scholar]
  38. Palmer R. M., Rees D. D., Ashton D. S., Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988 Jun 30;153(3):1251–1256. doi: 10.1016/s0006-291x(88)81362-7. [DOI] [PubMed] [Google Scholar]
  39. Peliowski A., Finer N. N., Etches P. C., Tierney A. J., Ryan C. A. Inhaled nitric oxide for premature infants after prolonged rupture of the membranes. J Pediatr. 1995 Mar;126(3):450–453. doi: 10.1016/s0022-3476(95)70467-1. [DOI] [PubMed] [Google Scholar]
  40. Pison U., López F. A., Heidelmeyer C. F., Rossaint R., Falke K. J. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol (1985) 1993 Mar;74(3):1287–1292. doi: 10.1152/jappl.1993.74.3.1287. [DOI] [PubMed] [Google Scholar]
  41. Putensen C., Räsänen J., López F. A. Improvement in VA/Q distributions during inhalation of nitric oxide in pigs with methacholine-induced bronchoconstriction. Am J Respir Crit Care Med. 1995 Jan;151(1):116–122. doi: 10.1164/ajrccm.151.1.7812540. [DOI] [PubMed] [Google Scholar]
  42. Radomski M. W., Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost. 1993 Jul 1;70(1):36–41. [PubMed] [Google Scholar]
  43. Rasmussen T. R., Kjaergaard S. K., Tarp U., Pedersen O. F. Delayed effects of NO2 exposure on alveolar permeability and glutathione peroxidase in healthy humans. Am Rev Respir Dis. 1992 Sep;146(3):654–659. doi: 10.1164/ajrccm/146.3.654. [DOI] [PubMed] [Google Scholar]
  44. Roberts J. D., Jr, Lang P., Bigatello L. M., Vlahakes G. J., Zapol W. M. Inhaled nitric oxide in congenital heart disease. Circulation. 1993 Feb;87(2):447–453. doi: 10.1161/01.cir.87.2.447. [DOI] [PubMed] [Google Scholar]
  45. Roberts J. D., Polaner D. M., Lang P., Zapol W. M. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992 Oct 3;340(8823):818–819. doi: 10.1016/0140-6736(92)92686-a. [DOI] [PubMed] [Google Scholar]
  46. Rossaint R., Falke K. J., López F., Slama K., Pison U., Zapol W. M. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993 Feb 11;328(6):399–405. doi: 10.1056/NEJM199302113280605. [DOI] [PubMed] [Google Scholar]
  47. Schedin U., Norman M., Gustafsson L. E., Herin P., Frostell C. Endogenous nitric oxide in the upper airways of healthy newborn infants. Pediatr Res. 1996 Jul;40(1):148–151. doi: 10.1203/00006450-199607000-00025. [DOI] [PubMed] [Google Scholar]
  48. Skinner J. R., Boys R. J., Hunter S., Hey E. N. Pulmonary and systemic arterial pressure in hyaline membrane disease. Arch Dis Child. 1992 Apr;67(4 Spec No):366–373. doi: 10.1136/adc.67.4_spec_no.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Stahlman M., Blankenship W. J., Shepard F. M., Gray J., Young W. C., Malan A. F. Circulatory studies in clinical hyaline membrane disease. Biol Neonate. 1972;20(3):300–320. doi: 10.1159/000240473. [DOI] [PubMed] [Google Scholar]
  50. Steinhorn R. H., Cox P. N., Fineman J. R., Finer N. N., Rosenberg E. M., Silver M. M., Tyebkhan J., Zwass M. S., Morin F. C., 3rd Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr. 1997 Mar;130(3):417–422. doi: 10.1016/s0022-3476(97)70203-8. [DOI] [PubMed] [Google Scholar]
  51. Stephens R. J., Freeman G., Evans M. J. Early response of lungs to low levels of nitrogen dioxide. Light and electron microscopy. Arch Environ Health. 1972 Mar;24(3):160–179. doi: 10.1080/00039896.1972.10666066. [DOI] [PubMed] [Google Scholar]
  52. Thusu K. G., Morin F. C., 3rd, Russell J. A., Steinhorn R. H. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1605–1610. doi: 10.1164/ajrccm.152.5.7582302. [DOI] [PubMed] [Google Scholar]
  53. Wagenvoort C. A. Misalignment of lung vessels: a syndrome causing persistent neonatal pulmonary hypertension. Hum Pathol. 1986 Jul;17(7):727–730. doi: 10.1016/s0046-8177(86)80182-4. [DOI] [PubMed] [Google Scholar]
  54. Walter U. Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev Physiol Biochem Pharmacol. 1989;113:41–88. doi: 10.1007/BFb0032675. [DOI] [PubMed] [Google Scholar]
  55. Walther F. J., Benders M. J., Leighton J. O. Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. Pediatrics. 1992 Dec;90(6):899–904. [PubMed] [Google Scholar]
  56. Wennmalm A., Benthin G., Petersson A. S. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol. 1992 Jul;106(3):507–508. doi: 10.1111/j.1476-5381.1992.tb14365.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wessel D. L., Adatia I., Giglia T. M., Thompson J. E., Kulik T. J. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation. 1993 Nov;88(5 Pt 1):2128–2138. doi: 10.1161/01.cir.88.5.2128. [DOI] [PubMed] [Google Scholar]
  58. Yoshida K., Kasama K. Biotransformation of nitric oxide. Environ Health Perspect. 1987 Aug;73:201–205. doi: 10.1289/ehp.8773201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Zobel G., Dacar D., Rödl S., Friehs I. Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets. Pediatr Res. 1995 Aug;38(2):198–204. doi: 10.1203/00006450-199508000-00011. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES